Eledon Pharmaceuticals Inc (ELDN NASDAQ) stock market data APIs
$2.388
0.26(10.9%)
as of November 12, 2026
Try our APIs with
free plan!
Eledon Pharmaceuticals Inc Financial Data Overview
Price chart is built with
Anychart
Eledon Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. It uses its immunology expertise in targeting the CD40 Ligand (CD40L) pathway to develop therapies to protect transplanted organs and prevent rejection, and to treat amyotrophic lateral sclerosis (ALS). The company's lead compound in development is tegoprubart, an IgG1 and anti-CD40L antibody with high affinity for CD40 Ligand, a biological target with therapeutic potential. It is also developing its products for the prevention of allograft rejection in kidney transplantation and xenotransplantation. The company has a collaboration agreement with eGenesis, Inc.; and a strategic collaboration with NewcelX Ltd. for the development of the NCEL-101 therapy for Type 1 Diabetes. The company was formerly known as Novus Therapeutics, Inc. and changed its name to Eledon Pharmaceuticals, Inc. in January 2021. Eledon Pharmaceuticals, Inc. is headquartered in Irvine, California.
Prev. Close
2.388
Open
2.6439
High
2.6755
Low
2.3791
52 wk Range
1.35-4.49
Market Cap
217 M
Shares Outstanding
81 261 K
Beta
0.961
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Eledon Pharmaceuticals Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Eledon Pharmaceuticals Inc data using free add-ons & libraries
Get Eledon Pharmaceuticals Inc Fundamental Data
Eledon Pharmaceuticals Inc Fundamental data includes:
- Net Revenue:
- EBITDA: -36 862 000
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
Get Eledon Pharmaceuticals Inc Earnings data
Corporate Events Calendar & News package for
$
19.99
/mo.
What’s included:
- Latest Release: 2026-11-13
- EPS/Forecast: -0.2
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Eledon Pharmaceuticals Inc News
New
Eledon rises on new mid-stage trial data, FDA fast track status for lead drug
[Currency-US Dollar Up] ModernLife Eledon Pharmaceuticals (ELDN [https://seekingalpha.com/symbol/ELDN]) traded higher on Tuesday after updating long-term data from a mid-stage trial for its lead cand...
A Diabetes Therapy Just Locked In Its Cell Supplier, and the Race to End Insulin Injections Is Heating Up
Issued on behalf of Avaí Bio, Inc. (OTCQB: AVAI) LAS VEGAS, July 21, 2026 /PRNewswire/ -- (American News Group News Commentary) For the millions of people who manage diabetes with daily insulin inje...
Weekly Buzz: IONS, MRK Get FDA Approvals; ACHV Gets CRL; ADCT Cuts Jobs; TECH Acquired
(RTTNews) - This week, the biotech sector delivered a mix of FDA and EU approvals, strategic reorganizations, layoff, acquisitions, and late-stage clinical readouts across oncology, metabolic disease,...
NTRA, Eledon From Partnership For Prospera Use In Phase 3 Kidney Transplant Trial
(RTTNews) - Natera, Inc. (NTRA), a clinical-stage company in cell-free DNA and precision medicine, and Eledon Pharmaceuticals, Inc. (ELDN), a clinical-stage biotechnology company developing immune-mo...
Get Eledon Pharmaceuticals Inc fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
Best Offer
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.